Upcoming events

Switch to Calendar View

• Member Forum Registration 2026

  • Start
    24 Feb 2026
  • End
    01 Feb 2027

  Register

  

  ANSA Member Forum Access Registration

  This event is used to register for access to the ANSA Member Forum, hosted in Google Groups. The forum is a member benefit and only active members will be provided access.

  Important: Use your Google-linked email address

  Members must register using the email address they use with Google to access the Forum. If your ANSA membership email is different, please ensure you register here with your Google email.

  After you register

  1. ANSA will confirm your membership status.
  2. You will be added to the Google Group using the email you register with on this page.
  3. You can then set your email frequency preferences inside Google Groups (each email, digest, abridged, or no email).

  
  

  Forum Rules

  Welcome to the Applied Neuroscience Society of Australasia (ANSA) Member Forum! To ensure a productive and respectful environment, we ask that all members adhere to the following rules:

  1. Content: Please only use this Forum for professional exchange on all matters of applied neuroscience, neuromodulation, neurofeedback. We welcome information and resource sharing, questions and collegial networking.
  2. Classifieds: Members wishing to share resources including products, training and services relevant to the ANSA community may post such information once per month. Only services, products or events related to brain function, health, neuroscience, biofeedback , assessment and/or treatment are able to be shared on this Forum. For such posts, the subject line MUST begin with the word: “Advertisement”.
  3. Confidentiality:
     1. Member privacy: Forum postings are not permitted to be forwarded to anyone outside of the subscribed users;
     2. Client privacy: if seeking specific consultation advice or referral options for a specific client, this Forum is not the appropriate place. Please ask (and share) about topics and information related to neuromodulation, but without reference to specific client characteristics which may compromise confidentiality, or which could be construed as a request for consultation on particular client.
  4. Forum etiquette:
     1. Know your audience: Please consider whether your post will add to the discussion in an informative way that will be of value to others, or whether it is best to send it privately. Please refrain from posting administrative messages “thank you,” “me too”, “remove me from the list” or personal comments that are directed only to the individual who sent the email. Before you send your message, check the “To:” field to determine if your message is addressed to the whole list or just the sender of the email.
     2. Use the subject line: Make the subject line descriptive so that recipients have a flavour of the message from glancing at the subject line, and can search archives by subject.
     3. Respect and courtesy: Treat all members with respect and courtesy. Disagreement is a natural part of professional discourse, but personal attacks, insults, or inflammatory comments are not appropriate for this Forum. Users may not use language or post content that is, including but not limited to, unlawful, harassing, abusive, defamatory, obscene, scandalous, inflammatory, pornographic or profane, or otherwise unprofessional. Users also should be cautious with humour and sarcasm in this professional Forum.
  5. Email Frequency: We want this Forum to bring members together, but we all have different preferences for email frequency. Choose the option that suits you (each email / digest or abridged / no email), by managing your subscriptions in Google Groups (be sure to use the email address your ANSA membership is linked to), click the Down arrow for the ANSA_Member_Forum.
  6. Responsibility and warranties: Forum members acknowledge that they are responsible for the information they submit and have full responsibility for the posting, including its legality, reliability, appropriateness, originality, and copyright. ANSA as a society accepts no responsibility for opinions and information posted on the Forum. ANSA disclaims all warranties with regard to information posted on this site. In no event shall ANSA be liable for any damages resulting from or in connection with the use of information posted on this site. Posts to the Forum are not legal advice, nor should any professional or clinical information shared on the Forum be relied upon by providers in their practice, without independent professional consultation. General information shared on the Forum is not a substitute for consulting a professional mentor or supervisor when this might be required. ANSA bears no responsibility for the opinions or information posted on the Forum, or their accuracy. The use of this ANSA Member Forum does not create supervisory or mentoring relationships. ANSA makes no warranties regarding the confidentiality of messages sent to the Forum. Users cannot assume that confidential or sensitive information posted to this Forum will remain so.
  7. Defamation: Do not post defamatory content on the Forum. Members are reminded that defamation laws in Australia prohibit the publication of false statements that harm the reputation of individuals or organizations. Be cautious in discussing legal, business, or personal matters. If unsure, seek moderator approval before posting. All members are personally responsible for the content they share and may be held liable for any defamatory material. This includes:
     1. False claims or accusations about other members, individuals, or entities;
     2. Any unsubstantiated statements that could damage someone's reputation.
  8. Copyright: Users may not post information or other material that is protected by copyright or use any words, logos, or other marks that would infringe upon a trademark or other intellectual property rights without permission of the owners.
  9. Moderation: ANSA reserves the right to moderate discussions, remove posts, or suspend members who violate the rules or ethical guidelines. Repeated or severe breaches of these rules, including violations of defamation laws, may result in permanent removal from the Forum. ANSA reserves the right to modify or discontinue the Forum at any time. The lists of subscribers also will be audited periodically to maintain the security and integrity of the Forum for the benefit of the members.
  10. Reporting Violations: please report any issues, questions or violations of these rules or the Ethical Code of Conduct, to the Forum moderator or secretary@appliedneuroscience.org.au.

  By participating in this Forum, you agree to adhere to these rules and engage in a manner that reflects the professional standards of ANSA.

  If you are registering on behalf of yourself, please double-check your registration email is the one you use for Google access to Groups.

  Show details
• ANSA 2026 Conference

  • Start
    12 Sep 2026
  •  
    8:30 AM
  • End
    13 Sep 2026
  •  
    5:00 PM
  • Location
    QT hotel, Gold Coast, QLD - Australia
  • Registered
    1 registrant

  Register

  Attend the 2026 ANSA Conference

  Neurotherapy Across the Lifespan

  QT Hotel Gold Coast • 12–13 September 2026

  The 2026 ANSA Conference is an Australasian event bringing together clinicians and practitioners working across neurofeedback, neuromodulation, and applied neuroscience, along with educators, students, and other professionals with an interest in the field. Through presentations, speakers, and shared clinical experience, the conference provides a strong learning environment alongside opportunities to connect with like-minded professionals. With a focus on real-world application, it explores how these approaches are used in practice to support assessment, intervention, and outcomes across the lifespan.
  
  Designed for clinicians seeking practical and clinically relevant insights, the program explores how neurotherapy approaches are applied in everyday settings, including assessment, protocol selection, and intervention strategies.

  This conference is suited to:

  • Clinicians using or exploring neurofeedback and neuromodulation approaches.
  • Practitioners seeking to apply EEG and QEEG findings to inform treatment decisions.
  • Professionals working with children, adolescents, and adults across the lifespan.
  • Mental health professionals, educators, and referring professionals looking to integrate practical, evidence-informed approaches into their work.
  • Students and early-career professionals developing skills in neurotherapy and applied neuroscience.
  • Clinicians at all stages of experience, from those starting out through to experienced practitioners refining their approach.

  Event Details

  Conference: 19th Applied Neuroscience Society of Australasia (ANSA) Conference – 2026

  Theme: Neurotherapy Across the Lifespan

  Dates: Saturday 12 September 2026 and Sunday 13 September 2026

  Venue: QT Hotel – Gold Coast, Queensland, Australia

  Keynote Speakers

  We are proud to announce the first of our keynote speakers. Additional speakers will be added as they are confirmed.

  

  Dr Tiff Thompson, Ph.D.

  School of Neurotherapy

  Tiff Thompson Ph.D. is a clinical neuroscientist, licensed therapist, educator, and EEG technologist. She is the CEO and Founder of The School of Neurotherapy, an online educational platform offering specialized curricula in Quantitative EEG Didactic training, Board Certification in Neurotherapy Didactic training, and Neuromodulation education. Dr. Thompson is also the CEO and founder and owner of NeuroField Neurotherapy, a Santa Barbara clinic where she addresses an array of conditions including mental health, brain injury, and neurodiverse issues.

  Members are invited to vote on the keynote topic:

  • Autism
  • Learning Disabilities
  • Trauma
  • Age-Related Cognitive Decline
  • Peak Performance

  Vote on Keynote Topic

  

  Dr Nicholas J. Dogris, Ph.D., BCN, QEEG-D

  Nicholas J. Dogris, Ph.D., BCN, QEEG-D is a licensed psychologist, neuroscientist, and pioneering neurotechnology innovator with over 25 years of clinical and research experience in EEG-based neurotherapy. He is CEO and co-founder of NeuroField, Inc., where he helped develop advanced EEG-synchronized neurostimulation and neuromodulation systems used to enhance brain function and treat conditions like anxiety, depression, ADHD, and traumatic brain injury. Dr. Dogris trains clinicians worldwide, holds board certification in neurofeedback and QEEG, and practices in Santa Barbara, California, blending cutting-edge technology with psychological expertise to improve neurological health and performance.

  Post-Conference Training

  

  School of Neurotherapy Bootcamp

  14–18 September 2026

  The NeuroField All-Levels Master Class. This intensive five-day training is designed to bring clinicians and technicians up to speed on the full range of NeuroField technologies and applications. Created with professionals of all experience levels in mind, this comprehensive course introduces EEG acquisition, quantitative EEG (QEEG) analysis, event-related potentials (ERPs), neurostimulation, and NeuroField neurofeedback through a combination of didactic lectures and hands-on training. Participants will learn practical techniques for collecting and interpreting brain data, applying neuromodulation protocols, and translating neurophysiological insights into clinical treatment strategies.

  Register for All levels Masterclass

  The School of Neurotherapy would like to hear from you about this and future training opportunities in Australia.

  Provide Training Feedback

  Enquiries

  secretary@appliedneuroscience.org.au

  Show details